Related Experiment Video
Updated: Sep 18, 2025

09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
21.8K
Decoding the Clinical Features that Associate with Progression, Causes, and Outcomes in Patients with Suspected
Yoav D Piura1, Nihal Satyadev1, Nick Corriveau-Lecavalier2
1Department of Neurology, Mayo Clinic in Florida, Jacksonville, Florida, USA.
Annals of Neurology
|June 20, 2025
Summary
Certain clinical signs can help identify patients with rapidly progressive dementia (RPD). Early detection of these features in suspected RPD cases improves diagnosis and prognosis.
Area of Science:
- Neurology
- Neuroscience
- Clinical Medicine
Background:
- Rapidly progressive dementia (RPD) presents a diagnostic challenge.
- Identifying early clinical features is crucial for timely diagnosis and management.
Purpose of the Study:
- To identify clinical features that predict the development of RPD in patients with suspected cases.
- To improve diagnostic accuracy and prognostic assessment for RPD.
Main Methods:
- A cohort of 248 patients with suspected RPD was analyzed retrospectively.
- Clinical data were reviewed by dementia specialists to diagnose RPD based on specific timelines of dementia onset or incapacitation.
- Univariate and multivariate analyses explored associations between clinical features and RPD diagnosis.
Main Results:
- 185 patients (74.6%) met RPD criteria. RPD patients were older and more frequently diagnosed with Alzheimer's disease or Creutzfeldt-Jakob disease.
- Specific features like visual agnosia, brain atrophy, and epileptiform discharges were exclusively found in RPD patients.
- Factors independently associated with RPD included intensive care unit admission, lack of seizures, abnormal MRI, and low CSF white blood cell count.
Conclusions:
- Clinical features can effectively identify patients likely to develop RPD.
- Early recognition of these indicators aids in accurate diagnosis and prognosis.
- This study provides valuable insights for clinicians managing suspected RPD cases.
Related Concept Videos
Dementia
182
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
182
Alzheimer's Disease: Overview
684
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
684
Parkinson's Disease: Overview
722
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
722
Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Parkinson's Disease: Treatment
391
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
391

